All In MedTech

FDA Clearance Tracker · P830079-S015

INSTAT COLLAGEN HEMOSTAT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 22, 2004 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 22, 2004

Approved

Time to decision

55 days

Received Apr 28, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P830079-S015
Device name
INSTAT COLLAGEN HEMOSTAT
Applicant
ETHICON, Inc.
Applicant location
Somerville, NJ
Received
Apr 28, 2004
Decided
Jun 22, 2004
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P830079

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A NEW STERILIZATION SITE LOCATED AT STERIS ISOMEDIX SERVICES, VEGA ALTA, PUERTO RICO; AND A LOWERED MINIMUM RADIATION STERILIZATION DOSE.

Source documents

Other decisions for ETHICON, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.